A Quantitative Proteomic Approach for Identification of Potential Biomarkers in Hepatocellular Carcinoma

Published on Oct 3, 2008in Journal of Proteome Research3.78
· DOI :10.1021/pr800197z
Raghothama Chaerkady34
Estimated H-index: 34
H. C. Harsha8
Estimated H-index: 8
(Johns Hopkins University)
+ 10 AuthorsPaul J. Thuluvath32
Estimated H-index: 32
(Johns Hopkins University)
Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide. In this study, our objective was to identify differentially regulated proteins in HCC through a quantitative proteomic approach using iTRAQ. More than 600 proteins were quantitated of which 59 proteins were overexpressed and 92 proteins were underexpressed in HCC as compared to adjacent normal tissue. Several differentially expressed proteins were not implicated previously in HCC. A subset of these proteins (six each from upregulated and downregulated groups) was further validated using immunoblotting and immunohistochemical labeling. Some of the overexpressed proteins with no previous description in the context of HCC include fibroleukin, interferon induced 56 kDa protein, milk fat globule-EGF factor 8, and myeloidassociated differentiation marker. Interestingly, all the enzymes of urea metabolic pathway were dramatically downregulated. Immunohistochemical labeling confirmed differential expression of fibroleukin, myeloid associated differentiation marker and ornithine carbamoyl transferase in majority of HCC samples analyzed. Our results demonstrate quantitative proteomics as a robust discovery tool for the identification of differentially regulated proteins in cancers.
  • References (0)
  • Citations (108)
📖 Papers frequently viewed together
3,396 Citations
195 Citations
2,138 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
Cited By108
A central characteristic of many types of cancer is altered energy metabolism processes such as enhanced glucose uptake and glycolysis and decreased oxidative metabolism. The regulation of energy metabolism is an elaborate process involving regulatory proteins such as HIF (pro-metastatic protein), which reduces oxidative metabolism, and some other proteins such as tumour suppressors that promote oxidative phosphorylation. In recent years, it has been demonstrated that signal transducer and activ...
1 CitationsSource
#1Letizia Satriano (UCPH: University of Copenhagen)H-Index: 1
#2Monika Lewinska (UCPH: University of Copenhagen)H-Index: 1
Last. Jesper B. Andersen (UCPH: University of Copenhagen)H-Index: 38
view all 5 authors...
Primary liver cancer (PLC) is the fourth most frequent cause of cancer-related death. The high mortality rates arise from late diagnosis and the limited accuracy of diagnostic and prognostic biomarkers. The liver is a major regulator, orchestrating the clearance of toxins, balancing glucose, lipid and amino acid uptake, managing whole-body metabolism and maintaining metabolic homeostasis. Tumour onset and progression is frequently accompanied by rearrangements of metabolic pathways, leading to d...
1 CitationsSource
#1Raghda Hassan (German University in Cairo)
#2Salma N. Tammam (German University in Cairo)
Last. Samar Mansour (German University in Cairo)
view all 7 authors...
Abstract Preventing hepatic stellate cell (HSC) activation represents a promising approach to resolve liver fibrosis. Several drugs have been reported to delay/prevent HSCs activation, however with limited clinical benefits. The latter may be in part attributed to the limited ability of such drugs in targeting more than one pathway of HSC activation. Added to that, is their inability of reaching their target cell in sufficient amounts to induce a therapeutic effect. In this work, chitosan NPs we...
#1Jake R. Conway (MIT: Massachusetts Institute of Technology)H-Index: 4
#2Eric Kofman (MIT: Massachusetts Institute of Technology)H-Index: 1
Last. E. M. Van Allen (MIT: Massachusetts Institute of Technology)H-Index: 49
view all 5 authors...
Immune checkpoint blockade (ICB) therapies, which potentiate the body’s natural immune response against tumor cells, have shown immense promise in the treatment of various cancers. Currently, tumor mutational burden (TMB) and programmed death ligand 1 (PD-L1) expression are the primary biomarkers evaluated for clinical management of cancer patients across histologies. However, the wide range of responses has demonstrated that the specific molecular and genetic characteristics of each patient’s t...
9 CitationsSource
#1Rom Keshet (Weizmann Institute of Science)H-Index: 7
#2Peter W. Szlosarek (QMUL: Queen Mary University of London)H-Index: 21
Last. Ayelet Erez (Weizmann Institute of Science)H-Index: 27
view all 4 authors...
Cancer cells reprogramme metabolism to maximize the use of nitrogen and carbon for the anabolic synthesis of macromolecules that are required during tumour proliferation and growth. To achieve this aim, one strategy is to reduce catabolism and nitrogen disposal. The urea cycle (UC) in the liver is the main metabolic pathway to convert excess nitrogen into disposable urea. Outside the liver, UC enzymes are differentially expressed, enabling the use of nitrogen for the synthesis of UC intermediate...
11 CitationsSource
#1Joo Sang Lee (UMD: University of Maryland, College Park)H-Index: 9
#2Lital Adler (Weizmann Institute of Science)H-Index: 3
Last. Ayelet Erez (Weizmann Institute of Science)H-Index: 27
view all 34 authors...
Summary The urea cycle (UC) is the main pathway by which mammals dispose of waste nitrogen. We find that specific alterations in the expression of most UC enzymes occur in many tumors, leading to a general metabolic hallmark termed "UC dysregulation" (UCD). UCD elicits nitrogen diversion toward carbamoyl-phosphate synthetase2, aspartate transcarbamylase, and dihydrooratase (CAD) activation and enhances pyrimidine synthesis, resulting in detectable changes in nitrogen metabolites in both patient ...
18 CitationsSource
#1M.A.B. Morais (University of Porto)H-Index: 2
#2Francisca Dias (University of Porto)H-Index: 7
Last. Rui MedeirosH-Index: 37
view all 4 authors...
Abstract Background Warburg Effect is a metabolic switch that occurs in most of cancer cells but its advantages are not fully understood. This switch is known to happen in renal cell carcinoma (RCC), which is the most common solid cancer of the adult kidney. RCC carcinogenesis is related to pVHL loss and Hypoxia Inducible Factor (HIF) activation, ultimately leading to the activation of several genes related to glycolysis. MicroRNAs (miRNAs) regulate gene expression at a post-transcriptional leve...
8 CitationsSource
Infection with hepatitis C virus (HCV) remains one of the serious human diseases worldwide, especially in Egypt, which can lead to cirrhosis or hepatocellular carcinoma (HCC). However, the exact molecular mechanism of HCC progress in HCV-infected patients remains unclear. Soluble fibrinogen-like protein 2 (sFGL2) is a modulator of the immune response that is secreted by T cells and inhibits maturation of dendritic cells and T cell proliferation. In the current study, serum sFGL2 levels were anal...
#1Ida Pucci-MinafraH-Index: 17
#2Gianluca Di CaraH-Index: 10
Last. S. Minafra (University of Palermo)H-Index: 15
view all 7 authors...
The present investigation has been conducted on one hundred tissue fragments of breast cancer, collected and immediately cryopreserved following the surgical resection. The specimens were selected from patients with invasive ductal carcinoma of the breast, the most frequent and potentially aggressive type of mammary cancer, with the objective to increase the knowledge of breast cancer molecular markers potentially useful for clinical applications. The proteomic screening; by 2D-IPG and mass spec...
2 CitationsSource
The biomarker development in metabolomics aims at discriminating diseased from normal subjects and at creating a predictive model that can be used to diagnose new subjects. From a case study on human hepatocellular carcinoma (HCC), we studied for the first time the potential usefulness of the emerging patterns (EPs) that come from the data mining domain. When applied to a metabolomics data set labeled with two classes (e.g., HCC patients vs healthy subjects), EP mining can capture differentiatin...
1 CitationsSource